Chiral Technologies
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Chiral Technologies - overview
Location
West Chester, PA, US
Primary Industry
Industrial Machinery
About
Chiral Technologies is a specialist in optical isomer separation solutions, primarily focusing on chiral chromatography for pharmaceutical and academic sectors. Their advanced technologies streamline the enantiomer separation process, enhancing research and drug development efficiency. Chiral Technologies provides optical isomer separation solutions. It is headquartered in West Chester, US.
The company was founded by professionals with prior expertise in the field, enhancing its credibility in chiral chromatography. There are no known pivots or structural changes in the company’s operations. Daicel Chiral Technologies specializes in optical isomer separation solutions, focusing primarily on chiral chromatography, which is crucial for pharmaceutical companies and academic researchers. Their product offerings include a variety of chiral columns and separation technologies that facilitate the enantiomer separation process, enabling clients to accelerate their research and drug development efforts.
The company provides expert assistance in selecting the appropriate chiral column and method tailored to specific separation applications, ensuring successful outcomes for projects ranging from small to large scale. The customer base includes pharmaceutical manufacturers, biotech firms, and academic institutions across North America, Europe, and Asia, all of which require high-quality separation solutions to produce effective and compliant pharmaceutical products. Daicel Chiral Technologies generates revenue through the sale of its specialized chiral columns and related separation services, primarily engaging in B2B transactions with pharmaceutical and academic clients. Typical transactions involve clients purchasing chiral columns as part of their research and development processes, along with ancillary services such as method development and technical support.
The pricing structure is designed to accommodate various project sizes, offering flexibility and scalability according to customer needs. The company's flagship products include a diverse range of chiral selectors, which are instrumental in the chiral chromatography process. Revenue is thus driven by both product sales and service agreements, fostering long-term partnerships with clients seeking reliable and effective separation solutions. Chiral Technologies is focused on expanding its product line with several new chiral columns scheduled to launch by the end of next year.
The company aims to penetrate new markets in Asia and Europe by 2025 to increase its global reach. Recent funding will be utilized to support these product developments and market expansions, ensuring that the company meets the growing demand for chiral separation solutions.
Primary Industry
Industrial Machinery
Sub Industries
Industrial Machinery, Commodity Chemicals
Website
www.chiraltech.com
Total Amount Raised
Subscriber access only
Chiral Technologies - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.